Funder
Takeda Science Foundation
Bayer Scholarship for Cardiovascular Research Foundation
Kanzawa Medical Research Foundation
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014;3:CD010813.
2. Sugiura K, Kobayashi T, Ojima T. Thromboembolism as the adverse event of combined oral contraceptives in Japan. Thromb Res. 2015;136:1110–5.
3. Sugiura K, Kobayashi T, Ojima T. Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanese women. Thromb Res. 2016;137:11–6.
4. Hasegawa S, Matsui T, Hane Y, Abe J, Hatahira H, Motooka Y, et al. Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese adverse drug event report database. PLoS One. 2017;12:e0182045.
5. Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009;339:b2890.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献